deCODE genetics (Nasdaq:DCGN) today announced that
its presentation at the Morgan Stanley Global Healthcare Unplugged conference
on Thursday, May 4, will be webcast live. The presentation will be delivered
at 2:15pm EDT/6:15pm GMT at the Mandarin Oriental hotel in Miami.
The webcast can be accessed through the Investors
page on deCODE’s website,
www.decode.com. Those interested in listening should log on a few minutes
in advance in order to download any software or complete any sign-in that
may be required.
About deCODE genetics
deCODE (Nasdaq:DCGN) is a
biopharmaceutical company applying its discoveries in human genetics to
the development of drugs for common diseases. deCODE is a global leader
in gene discovery - our population approach and resources have
enabled us to isolate key genes contributing to major public health
challenges from cardiovascular disease to cancer, genes that are
providing us with drug targets rooted in the basic biology of disease.
deCODE is also leveraging its expertise in human genetics and
integrated drug discovery and development capabilities to offer
innovative products and services in DNA-based diagnostics,
bioinformatics, genotyping, structural biology, drug discovery and
clinical development. deCODE is delivering on the promise of the new
genetics.SM Visit us on the web at www.decode.com.
